Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.
暂无分享,去创建一个
Grietje Molema | G. Molema | H. Moorlag | M. Everts | R. Kok | S. Ásgeirsdóttir | D. Meijer | Robbert J Kok | Maaike Everts | Sigridur A Asgeirsdóttir | Dirk K F Meijer | Astrid J Schraa | Erwin J Bos | Henk E Moorlag | A. J. Schraa | E. Bos
[1] F. Ross,et al. Superactivation of integrin alphavbeta3 by low antagonist concentrations. , 2001, Journal of cell science.
[2] E. Sackmann,et al. Selective adhesion of endothelial cells to artificial membranes with a synthetic RGD-lipopeptide. , 2001, Chemistry.
[3] E Ruoslahti,et al. Solution structures and integrin binding activities of an RGD peptide with two isomers. , 2001, Biochemistry.
[4] Fulvio Magni,et al. Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) , 2000, Nature Biotechnology.
[5] M. Schwaiger,et al. Carbohydrate Derivatives for Use in Drug Design: Cyclicαv-Selective RGD Peptides , 2000 .
[6] D. Schuppan,et al. Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor* , 2000, The Journal of Biological Chemistry.
[7] E. Ruoslahti,et al. An address system in the vasculature of normal tissues and tumors. , 2000, Annual review of immunology.
[8] G. FitzGerald,et al. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[9] Horst Kessler,et al. N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .
[10] Horst Kessler,et al. Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting , 1999 .
[11] D. Cheresh,et al. Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] B. Nies,et al. Selective RGD-Mediated Adhesion of Osteoblasts at Surfaces of Implants. , 1999, Angewandte Chemie.
[13] G. Bieler,et al. Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ , 1998, Nature Medicine.
[14] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[15] Grietje Molema,et al. Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature , 1997, Science.
[16] S. Goodman,et al. Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3 Antagonists , 1996 .
[17] M. R. Halie,et al. Basal tissue factor expression in endothelial cell cultures is caused by contaminating smooth muscle cells. Reduction by using chymotrypsin instead of collagenase. , 1995, Thrombosis research.
[18] Erkki Ruoslahti,et al. Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins , 1995, Bio/Technology.
[19] A. Habeeb,et al. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. , 1966, Analytical biochemistry.
[20] F. Greenwood,et al. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.
[21] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.